Diacetyldiamidoximeester of pentamidine, a prodrug for treatment of protozoal diseases: synthesis, in vitro and in vivo biotransformation.
about
Structural characterization of inhibitor complexes with checkpoint kinase 2 (Chk2), a drug target for cancer therapyThe fourth mammalian molybdenum enzyme mARC: current state of research.Antiparasitic compounds that target DNA.The mammalian molybdenum enzymes of mARC.New prodrugs of the antiprotozoal drug pentamidine.Inhibitory effects on cytochrome p450 enzymes of pentamidine and its amidoxime pro-drug.
P2860
Diacetyldiamidoximeester of pentamidine, a prodrug for treatment of protozoal diseases: synthesis, in vitro and in vivo biotransformation.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Diacetyldiamidoximeester of pe ...... and in vivo biotransformation.
@en
Diacetyldiamidoximeester of pe ...... and in vivo biotransformation.
@nl
type
label
Diacetyldiamidoximeester of pe ...... and in vivo biotransformation.
@en
Diacetyldiamidoximeester of pe ...... and in vivo biotransformation.
@nl
prefLabel
Diacetyldiamidoximeester of pe ...... and in vivo biotransformation.
@en
Diacetyldiamidoximeester of pe ...... and in vivo biotransformation.
@nl
P2093
P2860
P356
P1433
P1476
Diacetyldiamidoximeester of pe ...... and in vivo biotransformation.
@en
P2093
Anja Bürenheide
Bernd Clement
Jörg Schwarz
Wolfgang Rieckert
P2860
P304
P356
10.1002/CMDC.200600079
P577
2006-11-01T00:00:00Z